Quit Smoking Symptom Relief Pellet
NDC 0220-9318
Product Information
Quit Smoking Symptom Relief (lobelia inflata whole, strychnos nux-vomica seed) is a UNAPPROVED HOMEOPATHIC-approved product labeled by Boiron. This medication is typically used as a allergens [cs]. It is supplied as a white pellet for oral administration. This product entry covers the primary NDC 0220-9318 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Clinical Specifications
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
Code Structure Chart
Product Details
What is NDC 0220-9318?
What are the uses of this product?
What are Active Ingredients of this product?
- LOBELIA INFLATA 6 [hp_C]/1 - A plant genus of the family CAMPANULACEAE used medicinally and is a source of LOBELINE.
- STRYCHNOS NUX-VOMICA SEED 30 [hp_C]/1
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- LOBELIA INFLATA (UNII: 9PP1T3TC5U)
- LOBELIA INFLATA (UNII: 9PP1T3TC5U) (Active Moiety)
- STRYCHNOS NUX-VOMICA SEED (UNII: 269XH13919)
- STRYCHNOS NUX-VOMICA SEED (UNII: 269XH13919) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- SUCROSE (UNII: C151H8M554)
- LACTOSE, UNSPECIFIED FORM (UNII: J2B2A4N98G)
Which are the Pharmacologic Classes of this product?
- Allergens - [CS]
- Cell-mediated Immunity - [PE] (Physiologic Effect)
- Increased Histamine Release - [PE] (Physiologic Effect)
- Increased IgG Production - [PE] (Physiologic Effect)
- Non-Standardized Plant Allergenic Extract - [EPC] (Established Pharmacologic Class)
- Plant Proteins - [CS]
- Seed Storage Proteins - [CS]
* Please review the full disclaimer at the bottom of this page.